Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
ROCKVILLE, Md. and SUZHOU, China, Nov. 22, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...
Tata Power Signs MoU with Asian Development Bank for US$4.25 Billion to Finance Key Clean Energy Power Projects
SINGAPORE, Nov. 21, 2024 /PRNewswire/ -- Tata Power, one of India's leading integrated power companies, and the Asian Development Bank (ADB) have signed a Memorandum of Understanding (MoU) coinciding with the ongoing Climate Conference (COP29) at...
CIMG Inc. Announces Agreements with Certain Distributors to Sell Maca Beverage in Lawson and uSmile PetroChina Stores
BEIJING, Nov. 21, 2024 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (NASDAQ: IMG), a company with a heritage in specialty coffee and an emerging business in broader consumer food and beverage products, today announced that Zhongyan Shangyue...